Clin Nucl Med

1. AHMADI M, Sahafi P, Elahifard H, Bahonar M, et al
   Focal Radioiodine Uptake in the Lower Limb: A Benign Mimicker of Metastasis in High-risk Differentiated Thyroid Cancer.
   Clin Nucl Med. 2025 Sep 17. doi: 10.1097/RLU.0000000000006136.
   

   >> Share

   
   

   
   Eur Thyroid J

2. QUATTROCHI F, Grunenwald S, Caron P
   Apalutamide treatment and refractory hypothyroidism: effects of apalutamide on levothyroxine metabolism.
   Eur Thyroid J. 2025;14:e250185.
   

   >> Share

   
   
3. TOFT KRISTENSEN T, Plaschke CC, Fog Lomholt A, Holst Hahn C, et al
   Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer.
   Eur Thyroid J. 2025;14:e240282.
   

   >> Share

   
   

   
   PLoS One

4. SHU T, Wu X, Wei C, Chen C, et al
   ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway.
   PLoS One. 2025;20:e0328881.
   

   >> Share

   
   
5. CHUKIR T, Yaghmour M, Almutairi T, Chagoury O, et al
   Weight and body composition outcomes with liraglutide in individuals with well-treated hypothyroidism: A retrospective case-control study.
   PLoS One. 2025;20:e0332091.
   

   >> Share

   
   
6. LI F, Chen W, Chen Z, Lian B, et al
   Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.
   PLoS One. 2025;20:e0332136.
   

   >> Share

   
   

   
   Thyroid

7. SALIM HA, Msherghi A, Learned K, Zafereo M, et al
   Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.
   Thyroid. 2025 Sep 4. doi: 10.1177/10507256251372639.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share